The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
- David J. Gross*
- , Gabriel Munter
- , Menachem Bitan
- , Tali Siegal
- , Alberto Gabizon
- , Ronny Weitzen
- , Ofer Merimsky
- , Aliza Ackerstein
- , Asher Salmon
- , Avishai Sella
- , Shimon Slavin
*Corresponding author for this work
- Hadassah University Medical Centre
- Shaare Zedek Medical Center
- Sheba Medical Center at Tel Hashomer
- Tel Aviv Sourasky Medical Center
- Assaf Harofeh Medical Center
Research output: Contribution to journal › Article › peer-review
132
Scopus
citations